Dr ANN Gail Hayes
Dr ANN Gail Hayes was appointed in a total of 9 companies and resigned from 8 of these appointments.
Role
Director
Country Of Residence
Unreported
Nationality
British
Date of Birth
March 1952
Occupations
Pharmaceutical Consultant • Scientist • Consultant • Company Director • Pharmacologist
Active
0
Resigned
8
Dissolved
1
Other
0
Total
9
Companies
| Company | Timeline | Status | |
| Ieso Digital Health Limited Director • Pharmaceutical Consultant | 1 Mar 2011←6 Years→8 Sep 2017 | Active | |
| British Pharmacological Society Director • Pharmaceutical Consultant | 1 Jan 2010←3 Years→31 Dec 2012 | Active | |
Curidium Medica Limited Director • Scientist | 6 Jul 2006←2 Years 8 Months→3 Mar 2009 | Dissolved | |
| Plethora Solutions Holdings Plc Director • Director | 1 Mar 2005←4 Years→25 May 2009 | Active | |
Curidium Limited Director • Consultant | 1 Feb 2005←4 Years→3 Mar 2009 | Dissolved | |
Ionix Pharmaceuticals Limited Director • Consultant | 14 Jun 2002←3 Years→26 Jul 2005 | Dissolved | |
The ANN Hayes Consultancy Limited Director • Company Director | 18 Dec 2001←13 Years→10 Mar 2015 | Dissolved | |
Ionix Pharmaceuticals Limited Director • Consultant | 27 Jun 2001←11 Months→14 Jun 2002 | Dissolved | |
| British Pharmacological Society Director • Pharmacologist | 31 Dec 1993←1 Year→31 Dec 1994 | Active | |
Mutual People
- Robert St John SmithCuridium Medica Limited and Curidium Limited are mutual companies.
- Mr Timothy James SykesCuridium Medica Limited and Curidium Limited are mutual companies.
- Swift Incorporations LimitedPlethora Solutions Holdings Plc and Ionix Pharmaceuticals Limited are mutual companies.
- Professor Norman George BoweryBritish Pharmacological Society is a mutual company.
- Professor Humphrey Peter RangBritish Pharmacological Society is a mutual company.
- Dr Mary Jennifer MaclaganBritish Pharmacological Society is a mutual company.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
